Coronado Biosciences to Present at the Lazard Capital Markets 9th Annual Healthcare Conferencec

BURLINGTON, Mass., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Bobby W. Sandage, Jr., President and CEO of Coronado, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 4:00 PM EST. The conference will be held at The Pierre Hotel in New York City on November 13-14, 2012.